Abbott Unveils Late-Breaking Data Showing Intravascular Imaging via OCT Can Improve Stent Procedural Outcomes, Especially in Complex Cases

• Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement

Source: Abbott.com - August 27, 2023 Category: Pharmaceuticals Source Type: news